Case Study: A Promising Device Fails in the Market Due to Usability Issues episode artwork

EPISODE · Jun 9, 2025 · 11 MIN

Case Study: A Promising Device Fails in the Market Due to Usability Issues

from Let's Talk Risk! with Dr. Naveen Agarwal · host Naveen Agarwal, Ph.D.

In March, 2025, FDA announced the Class I recall of the Tack Endovascular System (TES), indicated for treating dissection of the blood vessels after they are widened using a balloon or stent (angioplasty):Philips is recalling Tack Endovascular Systems due to challenges experienced by customers during use, including events where additional interventions were required to retrieve or remove the Tack implant. All customers should stop using the Tack Endovascular System immediately. Philips will no longer distribute this system for use.In an Urgent Field Safety Notice sent to customers, Philips disclosed potential harms to patients:The following harms were observed or could reasonably be expected: failure to resolve dissection, migration of implant, bailout stenting, reintervention, unintended removal of tack devices, and ischemia.TES was an innovative solution to a tough medical problem - treating dissections below the knee, where complex anatomical variations present unique challenges not easily resolved using conventional stents. So, what went wrong? Innovative technology, FDA-approved device, excellent safety and effectiveness results in multiple clinical trials. Apparently these were not sufficient for market success.🎧Listen to this brief audio summary of this case and lessons QA/RA and Clinical professionals can apply in practice.Thanks for reading Let's Talk Risk!. This post is public so feel free to share it.Note:The audio summary was prepared using Google NotebookLM, an AI-enabled research tool. A total of 16 sources were used to generate this summary. Here are a few key resources:* P180034, Intact Vascular, Inc., Approved April 2019.* P190027, Intact Vascular, Inc., Approved April 2020.* Philips Press Releases, Issued April 27, 2020, June 03, 2021, June 13, 2022.* Philips Urgent Fields Safety Notice, January 2025.* Anatomy, Bone Pelvis and Lower Limb: Popliteal Artery, https://www.ncbi.nlm.nih.gov/books/NBK537125/.* Popliteal Artery and Its Branches; AJR 150:435-437, February 1988, 0361 -803X/88/1 502-0435 © American Roentgen Ray Society. This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit naveenagarwalphd.substack.com/subscribe

Episode metadata supplied by the publisher feed · Published Jun 9, 2025

Embed this episode

NOW PLAYING

Case Study: A Promising Device Fails in the Market Due to Usability Issues

0:00 11:23

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Let's Talk Risk! with Dr. Naveen Agarwal?

This episode is 11 minutes long.

When was this Let's Talk Risk! with Dr. Naveen Agarwal episode published?

This episode was published on June 9, 2025.

Can I download this Let's Talk Risk! with Dr. Naveen Agarwal episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!